Certain Common Stock of Sarepta Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 13-DEC-2021. These Common Stock will be under lockup for 61 days starting from 13-OCT-2021 to 13-DEC-2021. Details: Company's directors and executive officers have entered into lock-up agreements with the underwriters prior to the commencement of this offering pursuant to which the company and each of these persons for a period of 60 days, after the date of this prospectus supplement, may not, subject to limited exceptions, without the prior written consent of the underwriters i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of the company's common stock or any other securities convertible into or exercisable or exchangeable for shares of the company's common stock or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the common stock, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of shares of the company's common stock or such other securities